Insider Sale: 10% owner at $TRDA Sells 3,733 Shares | TRDA Stock News

By: Quiver InsiderRadar, Automated

Posted: 2 minutes ago / Aug. 31, 2026 10:31 p.m. UTC

BIOVENTURES 2018, L.P. MPM, a 10% owner of $TRDA, sold 3,733 shares of the company on 08-28-2026 for an estimated $26,168. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.1% of their shares of this class of stock. Following this trade, they now own 4,275,693 shares of this class of $TRDA stock.

$TRDA Insider Trading Activity

$TRDA insiders have traded $TRDA stock on the open market 30 times in the past 6 months. Of those trades, 1 have been purchases and 29 have been sales.

Here’s a breakdown of recent trading of $TRDA stock by insiders over the last 6 months:

• KUSH PARMAR has made 0 purchases and 5 sales selling 271,729 shares for an estimated $1,885,964.
• VENTURES V, L.P. 5AM has made 0 purchases and 4 sales selling 179,285 shares for an estimated $1,238,856.
• BIOVENTURES 2014, L.P. MPM has made 0 purchases and 6 sales selling 149,628 shares for an estimated $1,077,322.
• BIOVENTURES 2018, L.P. MPM has made 0 purchases and 6 sales selling 149,628 shares for an estimated $1,077,322.
• NATHAN J DOWDEN (President & COO) has made 0 purchases and 3 sales selling 30,010 shares for an estimated $425,723.
• NATARAJAN SETHURAMAN (President, Research & Develop.) sold 25,907 shares for an estimated $398,809
• KORY JAMES WENTWORTH (Chief Financial Officer) has made 0 purchases and 4 sales selling 26,965 shares for an estimated $344,645.
• BERNHARDT G ZEIHER purchased 5,000 shares for an estimated $29,316

To track insider transactions, check out Quiver Quantitative’s insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$TRDA Hedge Fund Activity

We have seen 78 institutional investors add shares of $TRDA stock to their portfolio, and 58 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MERCK & CO., INC. added 1,739,768 shares (+inf%) to their portfolio in Q2 2026, for an estimated $12,804,692
• MPM BIOIMPACT LLC added 1,253,053 shares (+inf%) to their portfolio in Q2 2026, for an estimated $9,222,470
• TCG CROSSOVER MANAGEMENT, LLC removed 1,227,270 shares (-53.7%) from their portfolio in Q2 2026, for an estimated $9,032,707
• AQR CAPITAL MANAGEMENT LLC added 620,044 shares (+780.0%) to their portfolio in Q2 2026, for an estimated $4,563,523
• JPMORGAN CHASE & CO added 496,457 shares (+inf%) to their portfolio in Q2 2026, for an estimated $3,653,923
• JONES HILL CAPITAL LP removed 374,010 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $2,752,713
• MILLENNIUM MANAGEMENT LLC added 244,603 shares (+47.1%) to their portfolio in Q2 2026, for an estimated $1,800,278

To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$TRDA Price Targets

Multiple analysts have issued price targets for $TRDA recently. We have seen 2 analysts offer price targets for $TRDA in the last 6 months, with a median target of $20.0.

Here are some recent targets:

• Debjit Chattopadhyay from Guggenheim set a target price of $17.0 on 06/08/2026
• Francois Brisebois from Oppenheimer set a target price of $23.0 on 04/06/2026

This article is not financial advice. See Quiver Quantitative’s disclaimers for more information.